Diagnostic blood chemistry testing accounts for 70% of the information needed to make an accurate patient diagnosis. But there is no access to these critical tests 50% of the time.
25 primary blood tests represent 80% of all testing volume accounting for more than 2 billion tests per year and over $20 billion in expenditures. There is no single instrument capable of performing the 25 primary tests.
The in vitro diagnostics industry is one of the largest and fastest growing segments in healthcare, but traditional central lab-based testing has not fundamentally changed over the past 30 years. The facts present a compelling need.
Growing demand for decentralized testing. Healthcare is rapidly decentralizing on a global basis as providers seek to increase efficiencies, improve clinical outcomes and decrease costs. The vast majority of patient care around the world today is provided in medical clinics with low to moderate test volumes.
Lack of access to critical tests. Relying on an external lab for patient test results presents an expensive and time consuming logistical challenge that can be solved in part by performing testing at the patient's side. However, the lack of a comprehensive and affordable solution for blood testing means providers in low and mid-volume care settings have no practical testing solution. This forces physicians to make diagnoses without data.
Significant market size. In developing countries, half the world's population is without quality diagnostics. Their growing middle class has the ability to pay for medical care, however, there is limited or no access to diagnostic testing. This is due to the prohibitive cost of traditional lab equipment and the lack of medical technicians required to perform the tests.
Ativa Medical is developing a micro-lab which incorporates multiple detection methods, allowing the 25 most frequent tests to be performed with a single portable instrument and test cards. It will enable critical hematology and chemistry testing to be affordably performed by general healthcare practitioners in all sites of care around the world.
In addition, the ability to conduct a broad range of tests with a single instrument provides an immediate comprehensive diagnostic picture, thereby enabling efficient management of disease and illness states.
The result? Expedited patient diagnosis, treatment, and disposition.